✦ LIBER ✦

KRAS Mutation Is an Important Predictor of Resistance to Therapy with Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors in Non-Small-Cell Lung Cancer

✍ Scribed by Massarelli, E.; Varella-Garcia, M.; Tang, X.; Xavier, A. C.; Ozburn, N. C.; Liu, D. D.; Bekele, B. N.; Herbst, R. S.; Wistuba, I. I.

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Mechanisms of Acquired Resistance to Epi

✍ Engelman, J. A.; Janne, P. A. 📂 Article 📅 2008 🏛 American Association for Cancer Research 🌐 English ⚖ 311 KB

Update of epidermal growth factor recept

✍ Chen, Yuh-Min 📂 Article 📅 2013 🏛 Elsevier Science 🌐 Chinese ⚖ 720 KB

Primary and Acquired Resistance to Epide

✍ Ayoola, Ayodele; Barochia, Amit; Belani, Kiran; Belani, Chandra P. 📂 Article 📅 2012 🏛 Informa plc 🌐 English ⚖ 403 KB

Everolimus synergizes with gefitinib in

✍ Dong, Song; Zhang, Xu-Chao; Cheng, Hua; Zhu, Jian-Quan; Chen, Zhi-Hong; Zhang, Y 📂 Article 📅 2012 🏛 Springer 🌐 English ⚖ 753 KB

Epidermal growth factor receptor tyrosin

✍ Roengvoraphoj, Monic; Tsongalis, Gregory J.; Dragnev, Konstantin H.; Rigas, Jame 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 695 KB

Supersensitive Mutation: Two Case Report

✍ James S. Myerson; Syed A. Iqbal; Mary E.R. O’Brien; Sanjay Popat 📂 Article 📅 2010 🏛 CIG Media Group, LP. 🌐 English ⚖ 102 KB